Dear Colleague:

The last time our industry faced an economic collapse of this magnitude, penicillin hadn’t been invented yet. We are truly operating in unchartered waters. As project managers, the success of your organizations to weather the storm falls largely upon your shoulders.

And there is no better opportunity to make sure that you stay ahead of the curve than by participating in the 6th Annual Project Management for the Drug & Device Industry. This is your best chance to hear practical case studies from your peers, network and problem solve with other PMs and walk away with a new set of tools that you can implement immediately upon your return from the meeting.

You will learn how to best get buy-in from upper management and team members to streamline your clinical development operations. This is your perfect opportunity to learn how your colleagues are dealing with budgetary restraints and what you can do to become a more efficient, effective project manager.

Simply put, the 6th Annual Project Management for the Drug & Device Industry is a must-attend event for any project manager who needs to learn how to:

• Better manage risk throughout the clinical development process to reduce unnecessary costs
• Increase the effectiveness of your team members by adding negotiation and conflict management skills to your toolkit
• Incorporate the biopharma model to create a more flexible and innovative project management-driven environment
• Maintain control of your operations when partnering with CROs to ensure consistent quality across your operations
• Create a fundamental shift within your organization to position project managers as team leaders

Take a moment now to review the program and register today to ensure you don’t miss taking advantage of our special early bird discounts. And don’t forget – BioPharmaPM members can save 25% off the cost of registration.

We look forward to seeing you in Orlando.

Kind regards,

Ian McRae Program Director IIR	Eric Morfin, PMP Partner Critical Skills Executive Director Amylin Pharmaceuticals